Skip to main content

Table 4 Patients with manifest cardiovascular diseases

From: From hypertension control to global cardiovascular risk management: an educational intervention in a cluster-randomised controlled trial

 

Complex intervention A n = 327

Simple intervention B n = 279

A vs. B

 

Mean FU

95% CI

Mean FU

95% CI

Difference/Odds ratio

95% CI

p

ICC

p

RR systolic [mmHg]

134.3

132.5-136.1

133.8

131.8-135.7

Δ = 0.5

-2.2-3.2

0.698

0.033

0.080

RR diastolic [mmHg]

78.1

77.0-79.2

79.1

77.9-80.2

Δ = -1.0

-2.5-0.6

0.243

0.048

0.020

Control rate RR < 140/90

59.2%

52.7%-65.7%

56.9%

49.9%-63.8%

OR = 1.11

0.73-1.70

0.632

0.076

0.015

Control rate RR < 160/95

90.2%

86.4%-93.9%

88.9%

84.7%-93.1%

OR = 1.15

0.66-1.99

0.623

0.037

0.280

Cholesterol [mg/dl]

197.8

194.1-201.6

199.8

195.8-203.9

Δ = -2.0

-7.6-3.6

0.482

0.000

1.000

Current smoker

15.2%

11.2%-19.1%

19.2%

15.1%-23.2%

OR = 0.57

0.26-1.26

0.163

0.258

0.005

ASS

73.0%

69.2%-76.7%

73.3%

69.3%-77.2%

OR = 0.96

0.46-2.01

0.917

0.230

<0.001

Statins

64.1%

57.2%-71.0%

48.2%

39.7%-56.7%

OR = 2.64

1.35-5.16

0.005

0.280

<0.001

  1. Outcomes at follow up in subpopulation at high CVR (10-year mortality ≥ 5%), but no manifest CVD (complete cases), adjusted for baseline and taking cluster effects into account by use of a mixed model.